Insmed (INSM) Tax Provisions (2010 - 2026)
Insmed (INSM) posted Tax Provisions of $1.9 million for Q2 2026, up 26.67% on a QoQ basis from $1.5 million in Q1 2026, and up 52.86% year-over-year from $1.2 million in Q2 2025.
Analysis
Insmed (INSM) Tax Provisions (2010 - 2026) Analysis & Trends
Insmed has reported Tax Provisions for 16 years, with the latest figure at $1.9 million in Q2 2026.
- On a quarterly basis, Tax Provisions rose 52.86% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $6.2 million, a 40.83% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, up 35.58% from the prior year.
- Tax Provisions was $1.9 million for Q2 2026 at Insmed, up from $1.5 million in the prior quarter.
- The five-year high for Tax Provisions was $1.9 million in Q2 2026, with the low at $100000.0 in Q4 2022.
- Average Tax Provisions over 5 years is $894111.1, with a median of $875000.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions slipped 19.45% in 2022, then soared 900.0% in 2023.
- Over 5 years, Tax Provisions stood at $100000.0 in 2022, then jumped by 900.0% to $1.0 million in 2023, then gained by 26.6% to $1.3 million in 2024, then gained by 20.54% to $1.5 million in 2025, then advanced by 24.51% to $1.9 million in 2026.
- The last three Tax Provisions figures came in at $1.9 million (Q2 2026), $1.5 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 393.00 Mn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 242.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 292.00 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 230.90 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | -59.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 15.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 34.90 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 1.90 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn | 44.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.90 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 912,000.00 |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 838,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 544,000.00 |
| Jun 30, 2023 | 530,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 501,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2021 | -83,000.00 |
| Sep 30, 2021 | -2.60 Mn |